Novel role of erythropoietin in proliferative diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 77, Issue 3 SUPPL., 2007, Pages

  Takagi, Hitoshi ^a,b   Watanabe, Daisuke ^a   Suzuma, Kiyoshi ^a   Kurimoto, Masafumi ^a   Suzuma, Izumi ^a   Ohashi, Hirokazu ^a   Ojima, Tomonari ^a   Murakami, Tomoaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Hyogo Prefectural Amagasaki Hospital   (Japan)

Author keywords

Angiogenesis; Diabetic retinopathy; Eythropoietin; Vascular endothelial growth factor

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; STAT5 PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; RADIOIMMUNOASSAY; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; VITREOUS BODY;

DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RETINAL VESSELS; RNA, MESSENGER; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547676210     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.035     Document Type: Article

References (8)

1. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y., et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274 (1999) 15732-15739
2. Takagi H., Koyama S., Seike H., Oh H., Otani A., Matsumura M., et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 44 (2003) 393-402
3. Ohashi H., Takagi H., Koyama S., Oh H., Watanabe D., Antonetti D.A., et al. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Mol. Vis. 10 (2004) 608-617
4. Oh H., Takagi H., Otani A., Koyama S., Kemmochi S., Uemura A., et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A novel mechanism contributing to VEGF-induced angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 383-388
5. Uemura A., Ogawa M., Hirashima M., Fujiwara T., Koyama S., Takagi H., et al. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110 (2002) 1619-1628
6. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 353 (2005) 782-792
7. Watanabe D., Suzuma K., Suzuma I., Ohashi H., Ojima T., Kurimoto M., et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 139 (2005) 476-481
8. Spaide R.F., and Fisher Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26 (2006) 275-278